Federal Appeals Court Hears AAM's Challenge Of Maryland Price Gouging Law

January 25, 2018 at 5:53 PM
Attorneys for the generic drug industry and Maryland jostled over the scope of the state's first-in-the-nation generic drug price gouging law during oral arguments Wednesday (Jan. 24) in their ongoing legal battle over the law. The arguments before the Federal Court of Appeals for the Fourth Circuit focused mostly on the Association for Accessible Medicines' view that the law violates the dormant Commerce Clause because it regulates sales between generic companies and wholesalers that occur outside of Maryland. While the...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.